Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

BioScience Health Innovations (BHIC) Enterprise Value (2020 - 2025)

BioScience Health Innovations (BHIC) has disclosed Enterprise Value for 6 consecutive years, with -$661925.0 as the latest value for Q4 2025.

  • Quarterly Enterprise Value changed 0.09% to -$661925.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$661925.0 through Dec 2025, changed 0.09% year-over-year, with the annual reading at -$661925.0 for FY2025, 0.09% changed from the prior year.
  • Enterprise Value for Q4 2025 was -$661925.0 at BioScience Health Innovations, up from -$1.1 million in the prior quarter.
  • The five-year high for Enterprise Value was -$374.0 in Q2 2021, with the low at -$1.3 million in Q2 2025.
  • Average Enterprise Value over 5 years is -$285189.2, with a median of -$56547.5 recorded in 2022.
  • The sharpest move saw Enterprise Value surged 98.36% in 2021, then crashed 6439.04% in 2022.
  • Over 5 years, Enterprise Value stood at -$96134.0 in 2021, then skyrocketed by 70.52% to -$28343.0 in 2022, then soared by 32.12% to -$19238.0 in 2023, then plummeted by 3343.79% to -$662517.0 in 2024, then rose by 0.09% to -$661925.0 in 2025.
  • According to Business Quant data, Enterprise Value over the past three periods came in at -$661925.0, -$1.1 million, and -$1.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.